SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950135-05-002634
Filing Date
2005-05-06
Accepted
2005-05-06 16:44:00
Documents
1
Effectiveness Date
2005-05-06

Document Format Files

Seq Description Document Type Size
1 TRANSKARYOTIC THERAPIES, INC. b55045dfdefa14a.htm DEFA14A 54956
  Complete submission text file 0000950135-05-002634.txt   56259
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-21481 | Film No.: 05808593
SIC: 2836 Biological Products, (No Diagnostic Substances)